Regentis Biomaterials Ltd. (RGNT)

CIK 0001912966 · Healthcare · Medical Instruments & Supplies

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
FY-2025
Latest FY-2025 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
—
Audit Information
—
Statements
Balance Sheets
—
Balance Sheets (P)
—
Statements of Comprehensive Income (loss)
—
Statements of Temporary Equity and Shareholders Equity (deficit)
—
Statements of Cash Flows
—
Notes
Commitments and Contingencies
—
Convertible Notes
—
Cybersecurity Risk Management and Strategy Disclosure
—
General
—
Insider Trading Policies and Procedures
—
Other Accounts Payable
—
Other Current Assets
—
Pay Vs Performance Disclosure
—
Related Party Transactions
—
Segment Reporting
—
Selected Statements of Comprehensive Income (loss) Data
—
Shareholders Equity (deficit)
—
Short-term Loans
—
Significant Accounting Policies
—
Subsequent Event Note
—
Taxes On Income
—
Temporary Equity
—
Warrant Liability
—